Recurrent erythema multiforme with oralinvolvement is therapeutically challenging.Apremilast has been used with success in resolvingthe oral aphthae of Behçet disease, prompting theuse of the drug in patients with oral erosions fromerythema multiforme. Three patients with oralerythema multiforme were given apremilast at dosesof 30-60mg daily. Complete clearance of the lesionswere observed in all three patients, including thoserefractory to other standard therapies. Apremilast maypresent an effective option for recurrent erythemamultiforme for patients who have failed trials antiviraland immunosuppressive therapies.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2jhKOgk
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
International Journal of Engineering Research and Applications (IJERA) is an open access online peer reviewed international journal that pub...
-
You could soon get an even more immersive VR experience thanks to the Ambiotherm plug in, which exposes you to the elements of your virtual...
-
Abstract T cell immunoglobulin and mucin domain 3 (Tim-3) is a critical regulatory molecule found on activated Th1 cells, exhausted CD8 + ...
-
Join in on the conversation about GCSE Statistics Coursework Help on the TSR community forums. from #AlexandrosSfakianakis via Alexandros ...
-
CFS, also known as ME, may be caused by the body switching from fully breaking down carbohydrates to using other energy sources, bringing o...
-
Study of Sharp Corner Cutting In Wire EDM Thesis submitted in accordance with The test specimens have been cut by using different wire-cut E...
-
Visit this site dedicated to Valentine from 100 Valentine Poems for your special person. Famous Valentine Poems from the Worlds greatest Poe...
-
Planta Med DOI: 10.1055/s-0043-106050 Glucose homeostasis is maintained by antagonistic hormones such as insulin and glucagon as well as ...
-
Cancerous tumours are voracious. Once they have consumed all the oxygen and nutrients in the original tumour site, the cancer cells travel t...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου